yellow pages news jobs events calendar movie times RSS News Feeds
Sacramento Today Events Calendar

Treatments For Neurodevelopmental Disorders Lecture

Share It




(SACRAMENTO, Calif.) - Alcino J. Silva, an internationally respected professor of Neurobiology, Psychiatry and Psychology, and director of the Integrative Center for Learning and Memory at UCLA, will discuss "Mechanisms and Adult Treatments for Neurodevelopmental Disorders" during the June UC Davis MIND Institute Distinguished Lecturer Series presentation.
 
The presentation will be offered on Wednesday, June 11 at 4:30 p.m. in the MIND Institute auditorium, 2825 50th St., Sacramento. It is free and open to the public and no reservations are required.
 
Silva's research has uncovered mechanisms and treatments for learning and memory disorders, including Neurofibromatosis type I, tuberous sclerosis, Noonan syndrome and schizophrenia. His findings illustrate how insights into the biology of molecular and cellular processes in the brain are changing our understanding of learning and memory disorders. Adult treatments could one day help the millions of people affected with neurodevelopmental and other learning and memory disorders.
 
A pioneer in the field of molecular and cellular cognition, Silva founded and is the first president of the Molecular and Cellular Cognition Society, an international organization with more than 5,000 members with branches in North America, Asia and Europe. In 2006 and 2007 he served as scientific director of the Intramural Program of National Institutes of Mental Health
 
His mouse model research has led to clinical trials for the first targeted treatments for learning disabilities. He has received numerous honors, including the Order of Prince Henry, MERIT award from the National Institute on Aging, Marco Canavezes Medal of Science and the Senior Roche Award for Translational Neuroscience. He is a fellow of the American Association for the Advancement of Science.
 
The UC Davis MIND Institute in Sacramento, Calif., was founded in 1998 as a unique interdisciplinary research center where families, community leaders, researchers, clinicians and volunteers work together toward a common goal: researching causes, treatments and eventual preventions and cures for neurodevelopmental disorders. The institute has major research efforts in autism, fragile X syndrome, chromosome 22q11.2 deletion syndrome, attention-deficit/hyperactivity disorder (ADHD) and Down syndrome. More information about the institute and its Distinguished Lecturer Series, including previous presentations in this series, is available on the Web at http://mindinstitute.ucdavis.edu.